EE318 Reduction of Costs Associated With the Use of Emicizumab in Prophylaxis in Pediatric Patients Diagnosed With Severe Hemophilia A and Inhibitors in El Salvador
Abstract
Authors
A Estrada C Galdámez D Castillo B Ventura